Form 8-K INFINITY PHARMACEUTICALS For: Nov 05

Go back to Form 8-K INFINITY PHARMACEUTICALS For: Nov 05

Infinity Pharma (INFI) Posts Surprise Q3 Profit

November 6, 2015 8:11 AM EST

Infinity Pharma (NASDAQ: INFI) reported Q3 EPS of $0.85, $1.48 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $90.7 million versus the consensus estimate of $24.85 million.

Revenue included a $75.2 million license fee associated with the $130 million milestone payment from AbbVie... More